PLRX · Pliant Therapeutics, Inc.

$1.16 +0.05 (+4.50%)

Market Cap

$68.73M

61.92M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bernard Coulie	M.D., Ph.D., M.B.A. President, Chief Executive Officer and Director	$682,000	—	$1,810,250	$2,713,750	$204,600	$52,301	$5,462,901
Éric Lefebvre	Former Chief Medical Officer	$571,861	$215,617	$508,541	$762,355	—	$666,486	$2,724,860
Keith Cummings	M.D., M.B.A. Chief Financial Officer	$503,876	$201,550	$631,081	$946,055	$100,775	$14,000	$2,397,337
Minnie Kuo	Chief Operating Officer	$470,696	$188,279	$307,464	$460,920	$103,553	$11,942	$1,542,854

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bernard Coulie	M.D., Ph.D., M.B.A. President, Chief Executive Officer and Director	$640,815	—	$2,234,936	$3,301,144	$384,489	$53,320	$6,614,704
Keith Cummings	M.D., M.B.A. Chief Financial Officer	$484,496	—	$963,560	$1,423,240	$213,178	$15,400	$3,099,874
Éric Lefebvre	Chief Medical Officer	$520,312	—	$748,176	$1,105,104	$228,937	$13,089	$2,615,618
Hans Hull	Chief Business Officer	$444,392	—	$549,360	$811,440	$195,532	$14,600	$2,015,324
Mike Ouimette	Chief Legal and Compliance Officer and Secretary	$442,936	—	$549,360	$811,440	$177,174	$13,350	$1,994,260

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bernard Coulie	M.D., Ph.D., M.B.A. President, Chief Executive Officer and Director	$610,300	—	$5,069,295	$5,099,736	$335,665	$51,003	$11,165,999
Éric Lefebvre	Chief Medical Officer	$500,300	—	$1,975,050	$1,977,600	$220,131	$13,980	$4,687,061
Keith Cummings	M.D., M.B.A. Chief Financial Officer	$452,800	—	$1,871,100	$1,883,664	$217,344	$14,000	$4,438,908
Hans Hull	Chief Business Officer	$427,300	—	$1,871,100	$1,883,664	$170,920	$4,293	$4,357,277
Mike Ouimette	Chief Legal and Compliance Officer and Secretary	$425,900	—	$1,351,350	$1,359,600	$170,360	$9,768	$3,316,978

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bernard Coulie	M.D., Ph.D., M.B.A. President, Chief Executive Officer and Director	$586,800	—	$6,424,000	$3,444,100	$440,000	$32,815	$10,927,715
Éric Lefebvre	Chief Medical Officer	$481,100	—	$2,044,000	$1,095,850	$269,416	$12,971	$3,903,337
Keith Cummings	M.D., M.B.A. Chief Financial Officer	$427,200	—	$1,810,400	$970,610	$222,144	$13,000	$3,443,354
Hans Hull	Chief Business Officer	$407,000	—	$1,642,517	$880,594	$211,640	$13,000	$3,154,751
Mike Ouimette	Chief Legal and Compliance Officer and Secretary	$398,000	—	$1,270,206	$680,993	$191,040	$2,009	$2,542,248

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bernard Coulie	M.D., Ph.D., MBA President, Chief Executive Officer and Director	$556,200	—	—	$4,301,775	$321,206	$42,172	$5,221,353
Éric Lefebvre	Chief Medical Officer	$455,981	—	—	$1,260,420	$246,230	$11,600	$1,974,231
Keith Cummings	M.D., MBA Chief Financial Officer	$401,700	—	—	$1,277,627	$192,816	$11,600	$1,883,743
Hans Hull	Chief Business Officer	$385,735	—	—	$1,071,142	$185,153	$11,600	$1,653,630
Barbara Howes	Former Chief Human Resources Officer	$254,521	—	—	$731,302	—	$10,090	$995,913
Mike Ouimette	General Counsel and Corporate Secretary	$362,693	—	—	$267,054	$174,092	$1,200	$805,039

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bernard Coulie	M.D., Ph.D. President, Chief Executive Officer and Director	$499,037	—	—	$1,496,556	$351,000	$45,229	$2,391,822
Éric Lefebvre	Chief Medical Officer	$425,462	—	—	$288,633	$209,176	$11,400	$874,671
Hans Hull	Chief Business Officer	$372,491	—	—	$279,025	$176,951	$11,400	$839,867

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bernard Coulie	M.D., Ph.D. President, Chief Executive Officer and Director	$428,108	$2,000	—	$1,673,280	$219,193	$49,905	$2,372,486
Hans Hull	Chief Business Officer	$355,137	$75,000	—	$268,560	$136,369	$11,200	$846,266

Executive changes

Person	Role	Change	Effective	Filed
Flavia Borellini, Ph.D.	Class II director	Appointed	2026-07-09	2026-07-13
Robert Iannone, M.D., M.S.C.E.	Class I director	Appointed	2026-07-09	2026-07-13

Key facts CIK 1746473 CUSIP 729139105 13F (30d) 85 filings 83 filers Visit website Investor relations